封面
市场调查报告书
商品编码
1873705

血糖监测系统(BGMS)-全球市占率和排名、总收入和需求预测(2025-2031年)

BGMS (Blood Glucose Monitoring System) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

出版日期: | 出版商: QYResearch | 英文 163 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球血糖监测系统 (BGMS) 市场规模估计为 165.88 亿美元,预计到 2031 年将成长至 320.02 亿美元,2025 年至 2031 年的复合年增长率为 9.7%。

血糖监测系统是一种用于测量和追踪血糖值的医疗设备或系统,尤其适用于糖尿病患者。这包括使用试纸和血糖仪的传统血糖自我监测(SMBG)设备,以及透过穿戴式感测器提供即时数据的更先进的连续血糖监测(CGM)系统。这些系统有助于患者及其医护人员管理血糖值、调整药物剂量,并预防低血糖和高血糖等併发症。

血糖监测系统市场的主要驱动力是全球糖尿病盛行率的上升,而糖尿病盛行率的上升又源自于人口老化、久坐不动的生活方式和不良的饮食习惯。人们对血糖控制重要性的认识不断提高、医疗保健成本的不断攀升以及政府对慢性病管理的支持,都推动了对持续血糖监测仪(CGM)和自我血糖监测仪(SMBG)的需求。智慧型手机连接、即时警报和非侵入式感测器等技术进步进一步促进了市场发展,尤其是在更年轻、更精通技术的患者群体中。

儘管市场需求强劲,仍面临许多挑战。设备成本高昂,尤其是动态血糖监测仪(CGM)和先进数位平台,限制了其在低收入和中等收入国家的普及。此外,使用者依从性和准确性(特别是设备使用不当和校准误差)的担忧也会影响临床疗效和患者信心。监管障碍、报销问题以及在竞争激烈的市场中保持差异化所需的持续创新,也给製造商带来了重大挑战。

本报告旨在按地区/国家、类型和应用对全球血糖值监测系统 (BGMS) 市场进行全面分析,重点关注总收入、市场份额和主要企业的排名。

本报告以收益为准,以 2024 年为基准年,对血糖监测系统 (BGMS) 市场规模、估算和预测进行了阐述,并包含了 2020 年至 2031 年的历史数据和预测数据。定量和定性分析将帮助读者制定业务/成长策略、评估市场竞争、分析自身在当前市场中的地位,并就血糖监测系统 (BGMS) 做出明智的商业决策。

市场区隔

公司

  • Abbott
  • Roche
  • Lifescan
  • Ascensia
  • ARKRAY
  • Sinocare
  • I-SENS
  • Terumo
  • B. Braun
  • Acon
  • Yicheng
  • Omron
  • SD Biosensor
  • 77 Elektronika
  • Yuwell
  • Osang Healthcare
  • AgaMatrix
  • Senseonics Holdings
  • Sinomedisite
  • Vivacheck
  • Empecs
  • Andon
  • Dexcom
  • Medtronic
  • Meiqi Medical
  • Medtrum Technologies
  • MicroTech Medical

按类型分類的细分市场

  • 血糖试纸
  • 血糖仪
  • CGM

应用领域

  • 医院
  • 家用

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for BGMS (Blood Glucose Monitoring System) was estimated to be worth US$ 16588 million in 2024 and is forecast to a readjusted size of US$ 32002 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.

A blood glucose monitoring system is a medical device or system used to measure and track blood glucose (sugar) levels in individuals, especially those with diabetes. It includes traditional self-monitoring blood glucose (SMBG) devices using test strips and glucometers, as well as advanced continuous glucose monitoring (CGM) systems that provide real-time data through wearable sensors. These systems help patients and healthcare providers manage blood sugar levels, adjust medications, and prevent complications like hypoglycemia or hyperglycemia.

The blood glucose monitoring system market is primarily driven by the global rise in diabetes prevalence, fueled by aging populations, sedentary lifestyles, and poor dietary habits. Growing awareness of the importance of glucose control, along with increased healthcare spending and government support for chronic disease management, is boosting demand for both continuous glucose monitors (CGMs) and self-monitoring blood glucose (SMBG) devices. Technological advancements such as smartphone connectivity, real-time alerts, and non-invasive sensors are further expanding the market, especially among younger and tech-savvy patients.

Despite strong demand, the market faces several challenges. High device costs, especially for CGMs and advanced digital platforms, limit access in low- and middle-income countries. In addition, user adherence and accuracy concerns-particularly with improper device usage or calibration errors-can impact clinical outcomes and patient trust. Regulatory hurdles, reimbursement issues, and the need for continuous innovation to differentiate in a competitive market also pose significant obstacles for manufacturers.

This report aims to provide a comprehensive presentation of the global market for BGMS (Blood Glucose Monitoring System), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of BGMS (Blood Glucose Monitoring System) by region & country, by Type, and by Application.

The BGMS (Blood Glucose Monitoring System) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BGMS (Blood Glucose Monitoring System).

Market Segmentation

By Company

  • Abbott
  • Roche
  • Lifescan
  • Ascensia
  • ARKRAY
  • Sinocare
  • I-SENS
  • Terumo
  • B. Braun
  • Acon
  • Yicheng
  • Omron
  • SD Biosensor
  • 77 Elektronika
  • Yuwell
  • Osang Healthcare
  • AgaMatrix
  • Senseonics Holdings
  • Sinomedisite
  • Vivacheck
  • Empecs
  • Andon
  • Dexcom
  • Medtronic
  • Meiqi Medical
  • Medtrum Technologies
  • MicroTech Medical

Segment by Type

  • Blood Glucose Test Strips
  • Blood Glucose Meter
  • CGM

Segment by Application

  • Hospital
  • Household

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of BGMS (Blood Glucose Monitoring System) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of BGMS (Blood Glucose Monitoring System) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of BGMS (Blood Glucose Monitoring System) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 BGMS (Blood Glucose Monitoring System) Product Introduction
  • 1.2 Global BGMS (Blood Glucose Monitoring System) Market Size Forecast (2020-2031)
  • 1.3 BGMS (Blood Glucose Monitoring System) Market Trends & Drivers
    • 1.3.1 BGMS (Blood Glucose Monitoring System) Industry Trends
    • 1.3.2 BGMS (Blood Glucose Monitoring System) Market Drivers & Opportunity
    • 1.3.3 BGMS (Blood Glucose Monitoring System) Market Challenges
    • 1.3.4 BGMS (Blood Glucose Monitoring System) Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global BGMS (Blood Glucose Monitoring System) Players Revenue Ranking (2024)
  • 2.2 Global BGMS (Blood Glucose Monitoring System) Revenue by Company (2020-2025)
  • 2.3 Key Companies BGMS (Blood Glucose Monitoring System) Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies BGMS (Blood Glucose Monitoring System) Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of BGMS (Blood Glucose Monitoring System)
  • 2.6 BGMS (Blood Glucose Monitoring System) Market Competitive Analysis
    • 2.6.1 BGMS (Blood Glucose Monitoring System) Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by BGMS (Blood Glucose Monitoring System) Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BGMS (Blood Glucose Monitoring System) as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Blood Glucose Test Strips
    • 3.1.2 Blood Glucose Meter
    • 3.1.3 CGM
  • 3.2 Global BGMS (Blood Glucose Monitoring System) Sales Value by Type
    • 3.2.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Type (2020-2031)
    • 3.2.3 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Household
  • 4.2 Global BGMS (Blood Glucose Monitoring System) Sales Value by Application
    • 4.2.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Application (2020-2031)
    • 4.2.3 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region
    • 5.1.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (2020-2025)
    • 5.1.3 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (2026-2031)
    • 5.1.4 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 5.2.2 North America BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 5.3.2 Europe BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 5.4.2 Asia Pacific BGMS (Blood Glucose Monitoring System) Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 5.5.2 South America BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions BGMS (Blood Glucose Monitoring System) Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 6.3.2 United States BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 6.4.2 Europe BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 6.5.2 China BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 6.6.2 Japan BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 6.7.2 South Korea BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 6.8.2 Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
    • 6.9.2 India BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Abbott
    • 7.1.1 Abbott Profile
    • 7.1.2 Abbott Main Business
    • 7.1.3 Abbott BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.1.4 Abbott BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Abbott Recent Developments
  • 7.2 Roche
    • 7.2.1 Roche Profile
    • 7.2.2 Roche Main Business
    • 7.2.3 Roche BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.2.4 Roche BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Roche Recent Developments
  • 7.3 Lifescan
    • 7.3.1 Lifescan Profile
    • 7.3.2 Lifescan Main Business
    • 7.3.3 Lifescan BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.3.4 Lifescan BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Lifescan Recent Developments
  • 7.4 Ascensia
    • 7.4.1 Ascensia Profile
    • 7.4.2 Ascensia Main Business
    • 7.4.3 Ascensia BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.4.4 Ascensia BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Ascensia Recent Developments
  • 7.5 ARKRAY
    • 7.5.1 ARKRAY Profile
    • 7.5.2 ARKRAY Main Business
    • 7.5.3 ARKRAY BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.5.4 ARKRAY BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.5.5 ARKRAY Recent Developments
  • 7.6 Sinocare
    • 7.6.1 Sinocare Profile
    • 7.6.2 Sinocare Main Business
    • 7.6.3 Sinocare BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.6.4 Sinocare BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Sinocare Recent Developments
  • 7.7 I-SENS
    • 7.7.1 I-SENS Profile
    • 7.7.2 I-SENS Main Business
    • 7.7.3 I-SENS BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.7.4 I-SENS BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.7.5 I-SENS Recent Developments
  • 7.8 Terumo
    • 7.8.1 Terumo Profile
    • 7.8.2 Terumo Main Business
    • 7.8.3 Terumo BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.8.4 Terumo BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Terumo Recent Developments
  • 7.9 B. Braun
    • 7.9.1 B. Braun Profile
    • 7.9.2 B. Braun Main Business
    • 7.9.3 B. Braun BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.9.4 B. Braun BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.9.5 B. Braun Recent Developments
  • 7.10 Acon
    • 7.10.1 Acon Profile
    • 7.10.2 Acon Main Business
    • 7.10.3 Acon BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.10.4 Acon BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Acon Recent Developments
  • 7.11 Yicheng
    • 7.11.1 Yicheng Profile
    • 7.11.2 Yicheng Main Business
    • 7.11.3 Yicheng BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.11.4 Yicheng BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Yicheng Recent Developments
  • 7.12 Omron
    • 7.12.1 Omron Profile
    • 7.12.2 Omron Main Business
    • 7.12.3 Omron BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.12.4 Omron BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Omron Recent Developments
  • 7.13 SD Biosensor
    • 7.13.1 SD Biosensor Profile
    • 7.13.2 SD Biosensor Main Business
    • 7.13.3 SD Biosensor BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.13.4 SD Biosensor BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.13.5 SD Biosensor Recent Developments
  • 7.14 11 Elektronika
    • 7.14.1 12 Elektronika Profile
    • 7.14.2 14 Elektronika Main Business
    • 7.14.3 16 Elektronika BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.14.4 18 Elektronika BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.14.5 19 Elektronika Recent Developments
  • 7.15 Yuwell
    • 7.15.1 Yuwell Profile
    • 7.15.2 Yuwell Main Business
    • 7.15.3 Yuwell BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.15.4 Yuwell BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Yuwell Recent Developments
  • 7.16 Osang Healthcare
    • 7.16.1 Osang Healthcare Profile
    • 7.16.2 Osang Healthcare Main Business
    • 7.16.3 Osang Healthcare BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.16.4 Osang Healthcare BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Osang Healthcare Recent Developments
  • 7.17 AgaMatrix
    • 7.17.1 AgaMatrix Profile
    • 7.17.2 AgaMatrix Main Business
    • 7.17.3 AgaMatrix BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.17.4 AgaMatrix BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.17.5 AgaMatrix Recent Developments
  • 7.18 Senseonics Holdings
    • 7.18.1 Senseonics Holdings Profile
    • 7.18.2 Senseonics Holdings Main Business
    • 7.18.3 Senseonics Holdings BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.18.4 Senseonics Holdings BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.18.5 Senseonics Holdings Recent Developments
  • 7.19 Sinomedisite
    • 7.19.1 Sinomedisite Profile
    • 7.19.2 Sinomedisite Main Business
    • 7.19.3 Sinomedisite BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.19.4 Sinomedisite BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.19.5 Sinomedisite Recent Developments
  • 7.20 Vivacheck
    • 7.20.1 Vivacheck Profile
    • 7.20.2 Vivacheck Main Business
    • 7.20.3 Vivacheck BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.20.4 Vivacheck BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.20.5 Vivacheck Recent Developments
  • 7.21 Empecs
    • 7.21.1 Empecs Profile
    • 7.21.2 Empecs Main Business
    • 7.21.3 Empecs BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.21.4 Empecs BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.21.5 Empecs Recent Developments
  • 7.22 Andon
    • 7.22.1 Andon Profile
    • 7.22.2 Andon Main Business
    • 7.22.3 Andon BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.22.4 Andon BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.22.5 Andon Recent Developments
  • 7.23 Dexcom
    • 7.23.1 Dexcom Profile
    • 7.23.2 Dexcom Main Business
    • 7.23.3 Dexcom BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.23.4 Dexcom BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.23.5 Dexcom Recent Developments
  • 7.24 Medtronic
    • 7.24.1 Medtronic Profile
    • 7.24.2 Medtronic Main Business
    • 7.24.3 Medtronic BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.24.4 Medtronic BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.24.5 Medtronic Recent Developments
  • 7.25 Meiqi Medical
    • 7.25.1 Meiqi Medical Profile
    • 7.25.2 Meiqi Medical Main Business
    • 7.25.3 Meiqi Medical BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.25.4 Meiqi Medical BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.25.5 Meiqi Medical Recent Developments
  • 7.26 Medtrum Technologies
    • 7.26.1 Medtrum Technologies Profile
    • 7.26.2 Medtrum Technologies Main Business
    • 7.26.3 Medtrum Technologies BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.26.4 Medtrum Technologies BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.26.5 Medtrum Technologies Recent Developments
  • 7.27 MicroTech Medical
    • 7.27.1 MicroTech Medical Profile
    • 7.27.2 MicroTech Medical Main Business
    • 7.27.3 MicroTech Medical BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
    • 7.27.4 MicroTech Medical BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
    • 7.27.5 MicroTech Medical Recent Developments

8 Industry Chain Analysis

  • 8.1 BGMS (Blood Glucose Monitoring System) Industrial Chain
  • 8.2 BGMS (Blood Glucose Monitoring System) Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 BGMS (Blood Glucose Monitoring System) Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 BGMS (Blood Glucose Monitoring System) Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. BGMS (Blood Glucose Monitoring System) Market Trends
  • Table 2. BGMS (Blood Glucose Monitoring System) Market Drivers & Opportunity
  • Table 3. BGMS (Blood Glucose Monitoring System) Market Challenges
  • Table 4. BGMS (Blood Glucose Monitoring System) Market Restraints
  • Table 5. Global BGMS (Blood Glucose Monitoring System) Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global BGMS (Blood Glucose Monitoring System) Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies BGMS (Blood Glucose Monitoring System) Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies BGMS (Blood Glucose Monitoring System) Product Type
  • Table 9. Key Companies Time to Begin Mass Production of BGMS (Blood Glucose Monitoring System)
  • Table 10. Global BGMS (Blood Glucose Monitoring System) Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BGMS (Blood Glucose Monitoring System) as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global BGMS (Blood Glucose Monitoring System) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global BGMS (Blood Glucose Monitoring System) Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global BGMS (Blood Glucose Monitoring System) Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global BGMS (Blood Glucose Monitoring System) Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global BGMS (Blood Glucose Monitoring System) Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global BGMS (Blood Glucose Monitoring System) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global BGMS (Blood Glucose Monitoring System) Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global BGMS (Blood Glucose Monitoring System) Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global BGMS (Blood Glucose Monitoring System) Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global BGMS (Blood Glucose Monitoring System) Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global BGMS (Blood Glucose Monitoring System) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (2020-2025) & (%)
  • Table 27. Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions BGMS (Blood Glucose Monitoring System) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions BGMS (Blood Glucose Monitoring System) Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Abbott Basic Information List
  • Table 32. Abbott Description and Business Overview
  • Table 33. Abbott BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Abbott (2020-2025)
  • Table 35. Abbott Recent Developments
  • Table 36. Roche Basic Information List
  • Table 37. Roche Description and Business Overview
  • Table 38. Roche BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Roche (2020-2025)
  • Table 40. Roche Recent Developments
  • Table 41. Lifescan Basic Information List
  • Table 42. Lifescan Description and Business Overview
  • Table 43. Lifescan BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Lifescan (2020-2025)
  • Table 45. Lifescan Recent Developments
  • Table 46. Ascensia Basic Information List
  • Table 47. Ascensia Description and Business Overview
  • Table 48. Ascensia BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Ascensia (2020-2025)
  • Table 50. Ascensia Recent Developments
  • Table 51. ARKRAY Basic Information List
  • Table 52. ARKRAY Description and Business Overview
  • Table 53. ARKRAY BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of ARKRAY (2020-2025)
  • Table 55. ARKRAY Recent Developments
  • Table 56. Sinocare Basic Information List
  • Table 57. Sinocare Description and Business Overview
  • Table 58. Sinocare BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Sinocare (2020-2025)
  • Table 60. Sinocare Recent Developments
  • Table 61. I-SENS Basic Information List
  • Table 62. I-SENS Description and Business Overview
  • Table 63. I-SENS BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of I-SENS (2020-2025)
  • Table 65. I-SENS Recent Developments
  • Table 66. Terumo Basic Information List
  • Table 67. Terumo Description and Business Overview
  • Table 68. Terumo BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Terumo (2020-2025)
  • Table 70. Terumo Recent Developments
  • Table 71. B. Braun Basic Information List
  • Table 72. B. Braun Description and Business Overview
  • Table 73. B. Braun BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of B. Braun (2020-2025)
  • Table 75. B. Braun Recent Developments
  • Table 76. Acon Basic Information List
  • Table 77. Acon Description and Business Overview
  • Table 78. Acon BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Acon (2020-2025)
  • Table 80. Acon Recent Developments
  • Table 81. Yicheng Basic Information List
  • Table 82. Yicheng Description and Business Overview
  • Table 83. Yicheng BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Yicheng (2020-2025)
  • Table 85. Yicheng Recent Developments
  • Table 86. Omron Basic Information List
  • Table 87. Omron Description and Business Overview
  • Table 88. Omron BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Omron (2020-2025)
  • Table 90. Omron Recent Developments
  • Table 91. SD Biosensor Basic Information List
  • Table 92. SD Biosensor Description and Business Overview
  • Table 93. SD Biosensor BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of SD Biosensor (2020-2025)
  • Table 95. SD Biosensor Recent Developments
  • Table 96. 77 Elektronika Basic Information List
  • Table 97. 77 Elektronika Description and Business Overview
  • Table 98. 77 Elektronika BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of 77 Elektronika (2020-2025)
  • Table 100. 77 Elektronika Recent Developments
  • Table 101. Yuwell Basic Information List
  • Table 102. Yuwell Description and Business Overview
  • Table 103. Yuwell BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Yuwell (2020-2025)
  • Table 105. Yuwell Recent Developments
  • Table 106. Osang Healthcare Basic Information List
  • Table 107. Osang Healthcare Description and Business Overview
  • Table 108. Osang Healthcare BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Osang Healthcare (2020-2025)
  • Table 110. Osang Healthcare Recent Developments
  • Table 111. AgaMatrix Basic Information List
  • Table 112. AgaMatrix Description and Business Overview
  • Table 113. AgaMatrix BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of AgaMatrix (2020-2025)
  • Table 115. AgaMatrix Recent Developments
  • Table 116. Senseonics Holdings Basic Information List
  • Table 117. Senseonics Holdings Description and Business Overview
  • Table 118. Senseonics Holdings BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 119. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Senseonics Holdings (2020-2025)
  • Table 120. Senseonics Holdings Recent Developments
  • Table 121. Sinomedisite Basic Information List
  • Table 122. Sinomedisite Description and Business Overview
  • Table 123. Sinomedisite BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 124. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Sinomedisite (2020-2025)
  • Table 125. Sinomedisite Recent Developments
  • Table 126. Vivacheck Basic Information List
  • Table 127. Vivacheck Description and Business Overview
  • Table 128. Vivacheck BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 129. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Vivacheck (2020-2025)
  • Table 130. Vivacheck Recent Developments
  • Table 131. Empecs Basic Information List
  • Table 132. Empecs Description and Business Overview
  • Table 133. Empecs BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 134. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Empecs (2020-2025)
  • Table 135. Empecs Recent Developments
  • Table 136. Andon Basic Information List
  • Table 137. Andon Description and Business Overview
  • Table 138. Andon BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 139. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Andon (2020-2025)
  • Table 140. Andon Recent Developments
  • Table 141. Dexcom Basic Information List
  • Table 142. Dexcom Description and Business Overview
  • Table 143. Dexcom BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 144. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Dexcom (2020-2025)
  • Table 145. Dexcom Recent Developments
  • Table 146. Medtronic Basic Information List
  • Table 147. Medtronic Description and Business Overview
  • Table 148. Medtronic BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 149. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Medtronic (2020-2025)
  • Table 150. Medtronic Recent Developments
  • Table 151. Meiqi Medical Basic Information List
  • Table 152. Meiqi Medical Description and Business Overview
  • Table 153. Meiqi Medical BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 154. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Meiqi Medical (2020-2025)
  • Table 155. Meiqi Medical Recent Developments
  • Table 156. Medtrum Technologies Basic Information List
  • Table 157. Medtrum Technologies Description and Business Overview
  • Table 158. Medtrum Technologies BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 159. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of Medtrum Technologies (2020-2025)
  • Table 160. Medtrum Technologies Recent Developments
  • Table 161. MicroTech Medical Basic Information List
  • Table 162. MicroTech Medical Description and Business Overview
  • Table 163. MicroTech Medical BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
  • Table 164. Revenue (US$ Million) in BGMS (Blood Glucose Monitoring System) Business of MicroTech Medical (2020-2025)
  • Table 165. MicroTech Medical Recent Developments
  • Table 166. Key Raw Materials Lists
  • Table 167. Raw Materials Key Suppliers Lists
  • Table 168. BGMS (Blood Glucose Monitoring System) Downstream Customers
  • Table 169. BGMS (Blood Glucose Monitoring System) Distributors List
  • Table 170. Research Programs/Design for This Report
  • Table 171. Key Data Information from Secondary Sources
  • Table 172. Key Data Information from Primary Sources

List of Figures

  • Figure 1. BGMS (Blood Glucose Monitoring System) Product Picture
  • Figure 2. Global BGMS (Blood Glucose Monitoring System) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global BGMS (Blood Glucose Monitoring System) Sales Value (2020-2031) & (US$ Million)
  • Figure 4. BGMS (Blood Glucose Monitoring System) Report Years Considered
  • Figure 5. Global BGMS (Blood Glucose Monitoring System) Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by BGMS (Blood Glucose Monitoring System) Revenue in 2024
  • Figure 7. BGMS (Blood Glucose Monitoring System) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Blood Glucose Test Strips Picture
  • Figure 9. Blood Glucose Meter Picture
  • Figure 10. CGM Picture
  • Figure 11. Global BGMS (Blood Glucose Monitoring System) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global BGMS (Blood Glucose Monitoring System) Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Hospital
  • Figure 14. Product Picture of Household
  • Figure 15. Global BGMS (Blood Glucose Monitoring System) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global BGMS (Blood Glucose Monitoring System) Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America BGMS (Blood Glucose Monitoring System) Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific BGMS (Blood Glucose Monitoring System) Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions BGMS (Blood Glucose Monitoring System) Sales Value (%), (2020-2031)
  • Figure 28. United States BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States BGMS (Blood Glucose Monitoring System) Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe BGMS (Blood Glucose Monitoring System) Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China BGMS (Blood Glucose Monitoring System) Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan BGMS (Blood Glucose Monitoring System) Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea BGMS (Blood Glucose Monitoring System) Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India BGMS (Blood Glucose Monitoring System) Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India BGMS (Blood Glucose Monitoring System) Sales Value by Application (%), 2024 VS 2031
  • Figure 49. BGMS (Blood Glucose Monitoring System) Industrial Chain
  • Figure 50. BGMS (Blood Glucose Monitoring System) Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed